Background and Purpose-Current transcranial Doppler criteria for vasospasm after aneurysmal subarachnoid hemorrhage are not age specific. We analyzed the effect of age on cerebral blood flow velocity changes after subarachnoid hemorrhage and constructed an age-adjusted predictive model of cerebral blood flow velocity in subarachnoid hemorrhage patients. Methods-We identified patients with aneurysmal subarachnoid hemorrhage admitted between 1991 and 1999 with a prospective transcranial Doppler database. Eighty-one patients, with complete medical records and transcranial Doppler examinations of the vessels of interest, were included. Patients were subdivided into 2 groups by age: younger, Ͻ68 years of age (nϭ47) and older, Ն68 years of age (nϭ34). Maximum mean flow velocity and incidence of symptomatic vasospasm were reported. Linear and nonlinear regression analyses were performed. Results-Middle cerebral artery and internal carotid artery mean flow velocity were lower in older patients ( 
C erebral angiography remains the gold standard for diagnosis of cerebral vasospasm (VSP). Since the introduction of transcranial Doppler (TCD), 1 various authors 2, 3 have reported on its usefulness as a noninvasive measurement of cerebral blood flow velocity (CBFV) within the circle of Willis for the evaluation of VSP in patients after aneurysmal subarachnoid hemorrhage (SAH). Currently patients are reported to have transcranial Doppler-defined VSP if CBFV is above a threshold velocity. This threshold varies among studies, even those pertaining to the same vessel. 4, 5 Sensitivity of TCD for detection of angiographic VSP in the middle cerebral artery (MCA) ranges from 39% to 85%. 4, 6 With advancing age, a decrease in CBFV and a concomitant increase in indexes of peripheral resistance are found in all vessels. These findings are more pronounced in subjects of age Ͼ40 years. 5, 7, 8 Current criteria for TCD-defined VSP are based predominantly on CBFV in younger patients without adjusting for factors such as age and days after SAH, which potentially limits their predictive power in older patients. Various studies have mentioned the effect of age on CBFV after SAH. 9 -12 Only 1 study 12 described a negative linear correlation between measured MCA maximum mean flow velocity (MMFV) and age (rϭϪ0.525, PϽ0.01) in SAH patients. Data-driven age-adjusted criteria may improve diagnostic capabilities of TCD.
The aim of this retrospective analysis is to determine the effect of age after SAH on (1) time profile of changes in TCD measured CBFV and (2) incidence of VSP. A secondary aim is to construct an age-adjusted predictive model of CBFV in SAH.
Subjects and Methods

Patients
We evaluated retrospectively all patients admitted to the Neurosciences Critical Care Unit with the diagnosis of aneurysmal SAH between 1991 and 1999. Patients were identified using a prospective TCD database maintained in the Neurosciences Critical Care Unit. Patients with traumatic and nonaneurysmal SAH were excluded. We reviewed medical records of all patients and collated data regarding demographic characteristics, clinical presentation, location of aneurysm, Fisher grade, 13 Hunt and Hess score, 14 and symptomatic VSP. Onset of SAH was presumed to be at headache onset.
Symptomatic VSP
Diagnosis of symptomatic VSP was based on onset of new focal or global neurological deficit not explained by hydrocephalus, hemorrhage, surgical complications, fever, infections, or metabolic abnormalities. Retrospective diagnosis was not attempted and was considered only (1) if made during the patient's hospital stay and (2) if symptoms resolved after either hypervolemic-hypertensive or endovascular therapy.
TCD Ultrasonography
MFV of the anterior circulation vessels was recorded in centimeters per second by a 2-MHz transducer (CDS, Medasonics; Intraview, RIMED) by use of a transtemporal approach. All vessels were insonated according to the method described by Aaslid et al. 1 Because it was shown that most patients with anterior circulation aneurysms who develop VSP have involvement of the basal arteries 15 and absence of accurate interdependence between VSP symptoms and actual arterial territory involved, 16, 17 our analysis was restricted to the M1 segment of the MCA and the C1 segment of the internal carotid artery (ICA) insonation. In addition, insonation of the MCA and of ICA segment C1 is more accurate and reproducible 4, 18 than of the ACA. 2, 5 We report MFV of the right M1 and left ICA segment C1. If the patient developed focal symptoms, we reported MFV of the side correlating with the symptoms.
Lindegaard ratio also was calculated to differentiate between hyperemia and VSP. 19 Patients were reported to have TCD VSP when mean CBFV was Ն100 cm/s 20 and Lindegaard ratio was Ͼ3. 19 We reported the following: (1) Gosling pulsatility index (PI) 21 and maximum MFV (MMFV); (2) baseline MFV defined as velocities recorded on the first 2 days of admission; (3) percentage change in MFV, defined as the difference between MMFV and baseline MFV divided by the baseline MFV; and (4) proportion of patients with Ն50-cm/s increase in MFV per 24 hours. 22 Length of the period between recording MMFV and diagnosis of symptomatic VSP was calculated.
Cerebral Angiography
Cerebral angiograms obtained during the patient's hospital stay were interpreted by a neuroradiologist and compared with those performed on admission. We defined angiographic VSP as a vessel lumen diameter reduction Ն51% because of the strong correlation between Ͼ50% reduction in vessel diameter and ischemic reduction in regional cerebral blood flow. 23 
Statistical Analysis
We analyzed data using SPSS 10.0 statistical software package (SPSS Inc 
Results
Demographic Data
We identified 311 patients with SAH. Of those, 25 had a traumatic SAH and 83 had a nonaneurysmal SAH. Only 81 of 203 (40%) had complete medical records and TCD examinations that included the vessels of interest (619 TCD studies were reviewed). Median patient age was 62 years (range 21 to 84 years); 75% were women. On presentation to the hospital, 41% had mild headache (Hunt and Hess score 1) and 4% were comatose (Hunt and Hess score 5). Forty-two percent had diffuse SAH on CT scan of the head (Fisher grade 2). Most of the aneurysms were in the anterior circulation (94%), of which 44% were anterior communicating artery aneurysms. Mean time to surgical or endovascular intervention was 2 days. A total of 90% (73 of 81) of the patients underwent clipping, and 8% (6 of 81) underwent endovascular coiling. One patient had no intervention, and both clipping and coiling was performed on another.
Scatterplot of CBFV by age ( Figure 1 ) demonstrated a sharper decline in CBFV for patients Ն68 years of age. This finding led us to dichotomize patients into 2 age groups: younger (nϭ47), defined as age Ͻ68 years; and older, (nϭ34) defined as age Ն68 years. No difference was seen between groups in relation to race, sex, Glasgow coma scale score, Hunt and Hess score and Fisher grade, aneurysm location, or type of vascular intervention performed.
Effect of Age on CBFV and PI
Older patients had a significantly lower baseline MFV and MMFV in both MCA and ICA. Table 1 illustrates the effect Figure 1 . Scatterplot of all MCA MFV recorded during patient hospital stay, which delineates a sharper decline in velocity for patients of age Ն68 years. This finding led to dichotomization of patients into either a younger age group defined as age Ͻ68 years or an older age group defined as age Ն68 years.
of age on MCA and ICA MFV. The number of days to MMFV was not significantly different between the 2 age groups. A total of 50% of patients reached MMFV on day 7 of SAH. We found a similar percentage change from baseline to MMFV in older and younger patients. We noted a trend toward a faster rise in MFV in younger patients. A total of 30% of younger patients versus 15% of older patients had MFV rise Ն50 cm/s per 24 hours (P‫.)70.0؍‬ We found a significantly higher proportion of younger patients with MMFV Ͼ160 cm/s (P‫.)50.0؍‬ Conversely, a higher proportion of older patients have MMFV Ͻ80 cm/s (Pϭ0.05).
We found a significant increase in PI with advancing age. The MCA PI was 0.88 in younger and 1.09 in older patients (PϽ0.0005). Similarly, ICA PI was 0.86 in younger and 1.2 in older patients (PϽ0.0005).
Effect of Age on Diagnosis of VSP
The most common presentation of symptomatic VSP in our study was confusion (66.7% in older and 55.6% in younger patients). Focal symptoms were found in 13.3% of older patients and 13% of younger patients. No significant difference was found in the presenting symptoms of VSP between older and younger patients. Older patients had a lower incidence and earlier onset of symptomatic VSP (Table 2) and developed symptomatic VSP at lower CBFV. Median time to symptomatic VSP was 5 and 7 days after SAH in older and younger patients, respectively (P‫.)60.0؍‬ MMFV preceded diagnosis of symptomatic VSP by 2 days in older and 1 day in younger patients (Pϭ0.7). A Kaplan-Meier curve ( Figure 2 ) demonstrated that none of the older patients developed symptomatic VSP after day 10 following SAH, whereas younger patients continued to develop symptomatic VSP until day 16. 
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Incidence of TCD-defined VSP was significantly higher in younger (42%) versus older (23%) patients (PϽ0.0001). Only 36 (44%) patients had cerebral angiograms performed as follow up or for possible VSP. Incidence of radiological VSP was 74% in younger and 47% in older patients (Pϭ0.1). Twenty-eight patients (35%) underwent TCD and angiographic studies on the same day symptomatic VSP was suspected. The incidence of angiographically confirmed TCD VSP was 53% in younger patients and 33% in older patients (Pϭ0.2).
Effect of Age on TCD Sensitivity and Specificity: Sensitivity and Specificity of TCD to Detect Symptomatic VSP Varied With Age
For the MCA, TCD sensitivity was higher in younger (60%) versus older (38%) patients. Conversely, specificity was higher in older (77%) compared with younger (58%) patients. For the ICA, TCD sensitivity was higher in younger (42.9%) compared with older (20%) patients; specificity was not different between groups (80%).
Regression Analysis
To analyze the age-related decline of MFV in the MCA and ICA, linear and quadratic regression models were constructed. Models are described in formulas 1 through 4. We entered the following variables into the model: (1) age, (2) SAH day (PSAHD), (3) SAH day category (SAHDC), and (4) clinical spasm (CSPASM). The variable SAHDC was introduced into the model to emphasize the change in CBFV seen late in the course of SAH. SAHDC was defined as 0 if SAH day was Յ12 and PSAHD-12 if SAH day was Ͼ12. CSPASM was defined as 0 when VSP was absent and "1" when VSP was present.
The Figure 3) . In the MCA, most of the decline in MFV occurred in older patients. The slope of this MFV decline is 9-fold in patients of age Ն68 versus Ͻ68 years. As for the ICA, most of the decline was in the younger patients. The slope of the decline is 8-fold in patients of age Ͻ68 versus Ն68 years.
Discussion
Results of the present study provide new insights into the effect of aging on CBFV in patients after aneurysmal SAH. First, we have shown that older SAH patients have lower MMFV and baseline MFV. Second, older patients developed symptomatic VSP at normal-range MFV. Third, older patients may have a shorter high-risk period to development of symptomatic VSP. Finally, the age-related decline in CBFV was not linear but instead was quadratic, and the slope of this decline varied with the type of vessel insonated.
Effect of age on CBFV and PI
Age-related decline in CBFV has been reported in previous studies. 9 -11,24 Although these studies clearly demonstrated an Figure 3 . Plot of quadratic model for SAH patients at days 9 and 10 after SAH without evidence of symptomatic VSP. A, In MCA, slope of MFV decline is 9-fold in patients Ն68 vs Ͻ68 years of age. B, In ICA, slope of decline is 8-fold in patients Ͻ68 vs Ն68 years of age.
inverse relationship between age and CBFV, a small sample size of patients Ͼ60 years of age did not allow the authors to perform multivariate logistic regression analysis and adjust for factors such as SAH day and presence of symptomatic VSP. The decline in CBFV with age may be associated with certain changes in cerebrovascular hemodynamics such as (1) decreased CBF or metabolic demands, 25, 26 (2) vessel-size changes, 27 and (3) lower cardiac output. 28, 29 Aging is associated with a 20% to 30% decrease in CBF in healthy individuals between the ages of 20 and 80 years. 25, 26 Several authors have examined the relationship between relative changes in CBFV and changes in CBF in normal subjects. 30, 31 A linear relationship has been reported between CBFV and the mean cerebral transit time of Tc 30 and between percentage change in MCA MFV and percentage change in CBF. 31 Although the linear relationships found in these studies do not meet the criterion of having a slope of 1 and a y intercept of 0, they suggest that changes in CBFV reflect changes in CBF. 30 Aging is also associated with dilatation of major extracranial arteries and reduction of flow within parenchymal vessels. 27 Kusunoki et al 27 demonstrated poor visibility of the intracerebral ICA and M1 segment of the MCA on magnetic resonance angiography secondary to progressive kinking, elongation, and stenosis with advancing age.
Several authors have examined the effect of aging on the cardiovascular system. 28, 29 These studies demonstrate an age-related prolongation of isovolumic cardiac relaxation, 28 which results in reduced efficacy of early ventricular diastolic filling and an age-related drop in cardiac index. 29 In the present study, along with a decrease in CBFV with advancing age comes an increase in PI. This may be secondary to age-related stiffening of the arteries, which often dilate and become tortuous. 32 The more-elastic (younger) vessels damp the pulse and pressure wave more effectively than do stiff, aged vessels. 33 Thus, aging increases the systolic-diastolic pressure ratio, which results in an increase in PI.
Effect of Age on VSP
VSP remains a major complication associated with aneurysmal SAH that results in delayed ischemic deficits in 2% to 24% of all cases. 34, 35 Our symptomatic VSP incidence was higher compared with Boecher-Schwarz et al. 12 They reported a 23% incidence of VSP in patients Ͻ55 and 0% in patients Ͼ55 years of age. Higher incidence of symptomatic VSP in our series is probably secondary to a higher degree of severity of SAH. Of our patients, 42% had a Hunt and Hess score Ն3 on admission, compared with 25% in the BoecherSchwarz series.
Incidence of TCD-defined VSP was higher in our series compared with the series of Sloan. 36 Sloan demonstrated that TCD VSP occurred in 28% of patients Ն55 and 13% of patients Ն65 years of age. Our higher incidence may be related to a lower CBFV cutoff (Ն100 cm/s) compared with the cutoff used by Sloan (120 cm/s). 36 Our incidence of angiographic VSP was comparable to published data. 37, 38 In 1 study, 37 the reported incidence of angiographic VSP was 75% in patients Ͻ60 and 45% in patients Ն60 years of age. Another study 38 reported angiographic VSP in 44% of patients Ͻ65 and 23% of patients Ն65 years of age.
The lower incidence of VSP in older patients may be secondary to the age-related increase in atherosclerosis, which results in impairment of contractility and elasticity of the muscle wall of small arteries and arterioles. 39, 40 Postmortem histological studies 41 have demonstrated that aging is accompanied by the appearance of collagen fibers in major intracranial arteries, which is usually associated with loss of elasticity of the vessel wall. Dewey et al 42 described a collapse of downstream vasculature as diastolic pressure falls below the critical closing pressure of cerebral blood vessels. He reported that younger patients, due to more compliant and collapsible vessels, may have greater diminution in CBF as cerebral perfusion pressure reaches a critical closing pressure. 42 Hence, elderly subjects with stiffer vessels may be able to maintain small-vessel patency at similar pressures.
In our series, older patients not only had a low CBFV, but also developed symptomatic VSP at normal-range CBFV. For older patients with SAH (whose resting CBF is lowest), the margin between adequate CBF and the ischemic threshold may become especially narrow. 43 Accordingly, we think that older patients would be susceptible to ischemic neurological deficits induced by small changes in vessel caliber. This discordance between TCD measured CBFV and CBF in older patients with SAH may be due to disturbances in cerebral autoregulation. 44 The high-risk period to development of symptomatic VSP usually extends from days 4 to 21, with a peak incidence around day 14 after SAH. 34 We found similar risk period in our younger patients, in whom the risk of symptomatic VSP was present until day 16 of SAH. Surprisingly, older patients had a shorter risk period. None of these patients developed symptomatic VSP after day 10 of SAH. We do not have a clear explanation as to the difference in risk-period duration. However, because the diagnosis of symptomatic VSP was not made prospectively, this finding will need to be tested prospectively before therapeutic inferences can be made.
Effect of Age on TCD Sensitivity and Specificity
High specificity and low sensitivity for detecting symptomatic VSP characterize TCD data after SAH in the present study. Specificity and sensitivity in MCA and ICA varied from 85% to 100% and from 25% to 94%, respectively, in the studies of Grolimund et al 5 and Sloan et al. 6 Neither of these studies have taken into account the effect of age on CBFV. Sloan 36 demonstrated that lowering the criterion for diagnosis of TCD VSP from 110 to 80 cm/s improved TCD specificity. In the present study, the high specificity and low sensitivity of TCD in elderly patients may be secondary to lower incidence of VSP and higher false-positive rate in those patients. The false-positive rate in older patients was 40% compared with 27% in younger patients.
Regression Model
Boecher-Schwarz et al 12 was the first to describe a negative linear correlation between the measured MCA MMFV and age (rϭϪ0.525, PϽ0.01) in SAH patients. In this linear model, the authors did not adjust for days of SAH when CFBV was measured and for presence of symptomatic VSP on that day. To our knowledge, the present study is the first to report an effect of age on CBFV using nonlinear regression analysis and adjusting for factors such as days after SAH and presence or absence of symptomatic VSP.
The slope of the age-related decline in CBFV varied with the vessel insonated and age group of the patients. Why the slopes of the MCA and ICA were not concordant is unclear. In the ICA, most patient MFV decline occurred at a younger age. In the MCA, the major decline in MFV occurred in older patients (Ն68 years). This pattern of CBFV changes appears to fit a quadratic model better than a linear model, as our analysis demonstrated. This predictive model could be extrapolated to create an age-adjusted nomogram for CBFV to improve sensitivity and specificity of TCD.
Finally, the present study has a few limitations. Our quadratic model is limited by the retrospective nature of some of the variables included in the analysis. The diagnosis of symptomatic VSP, although it was established through accurate chart review, is retrospective and could overestimate the incidence of VSP in the study. This diagnosis also could affect interpretation of the accuracy parameters of CBFV measured by TCD.
Despite these limitations, we were able to demonstrate in the present study the important nonlinear effect of age on CBFV in patients after SAH. The present study is the first to show that older patients develop symptomatic VSP at normalrange CBFV, which thus limits the application of TCD in the management of elderly SAH patients. An age-adjusted CBFV nomogram in SAH may improve accuracy of TCD in older patients.
